Neils David M, Virgo Katherine S, Longo Walter E, Ode Kenichi, Audisio Riccardo A, Shariff Umar S, Papettas Trifonas, McGarry Alaine E, Gammon Steven R, Johnson Frank E
Department of Surgery, Saint Louis University Medical Center, 3635 Vista Avenue at Grand Blvd., St. Louis, MO 63110-0250, USA.
Int J Oncol. 2007 Mar;30(3):735-42.
Most patients with rectal cancer are treated with curative-intent surgery; adjuvant chemotherapy and radiation are often used as well. A recent survey of members of the American Society of Colon and Rectal Surgeons (ASCRS) revealed considerable variation in surveillance intensity after primary treatment. We evaluated whether geographic factors may be responsible for the observed variation. Vignettes of hypothetical patients and a questionnaire based on the vignettes were mailed to the 1782 members of ASCRS. Repeated-measures analysis of variance was used to compare practice patterns, as revealed by the responses, according to US Census Regions and Divisions, Metropolitan Statistical Areas (MSA), and state-specific managed care organization (MCO) penetration rates. There was significant variation in surveillance intensity according to the US Census Region and Division in which the surgeon practiced. Non-US respondents employed CT of the abdomen and pelvis, chest radiography, and colonoscopy significantly more often than US respondents. MSA was not a significant source of variation. Surveillance patterns varied significantly by MCO penetration rate for office visits and CT of the abdomen and pelvis but not for other modalities. The US Census Region and Division in which the surgeon practices have a significant effect on surveillance intensity following completion of primary curative-intent therapy for rectal cancer patients. The MSA in which the surgeon practices does not affect surveillance intensity significantly and MCO penetration rate affects follow-up intensity minimally. All significant differences are clinically rather modest, however. These data should be useful in the design of controlled trials on this topic.
大多数直肠癌患者接受根治性手术治疗;辅助化疗和放疗也经常使用。最近对美国结肠和直肠外科医生协会(ASCRS)成员的一项调查显示,初次治疗后的监测强度存在很大差异。我们评估了地理因素是否可能是观察到的差异的原因。将假设患者的案例及基于这些案例的问卷邮寄给了1782名ASCRS成员。采用重复测量方差分析来比较根据美国人口普查区域和分区、大都市统计区(MSA)以及特定州的管理式医疗组织(MCO)渗透率得出的实践模式,这些模式由回复揭示。根据外科医生执业所在的美国人口普查区域和分区,监测强度存在显著差异。非美国受访者比美国受访者更频繁地使用腹部和盆腔CT、胸部X光检查以及结肠镜检查。MSA不是差异的显著来源。对于门诊就诊和腹部及盆腔CT,监测模式因MCO渗透率而有显著差异,但对于其他检查方式则不然。外科医生执业所在的美国人口普查区域和分区对直肠癌患者完成初次根治性治疗后的监测强度有显著影响。外科医生执业所在的MSA对监测强度没有显著影响,MCO渗透率对随访强度的影响最小。然而,所有显著差异在临床上都相当小。这些数据在设计关于该主题的对照试验时应会有用。